Showing results (961-970 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|January 22, 2022
Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2-A Candidate for Passive Immunization against COVID-19Hendris Wongso, Isa Mahendra, Wyanda Arnafia, et al.
Vaccines|January 22, 2022
Tetanus Vaccination Status and Vaccine Hesitancy in Amateur Basketball Players (Italy, 2020)Matteo Riccò, Simona Peruzzi
Vaccines|April 23, 2022
Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 EnvelopeDiana Aguado-Garcia, Alex Olvera, Christian Brander, et al.
Vaccines|April 23, 2022
Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA VaccineMohammad Said Ashenagar, Akiko Matsumoto, Hironori Sakai, et al.
Vaccines|April 23, 2022
COVID-19 Vaccination Willingness and Vaccine Uptake among Healthcare Workers: A Single-Center ExperienceMarija Zdravkovic, Viseslav Popadic, Vladimir Nikolic, et al.
Vaccines|April 23, 2022
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 InfectionMiguel Hueda-Zavaleta, Juan C Gómez de la Torre, José Alonso Cáceres-Del Aguila, et al.
Vaccines|April 23, 2022
Human Papillomavirus Vaccine Hesitancy Highly Evident among Caregivers of Girls Attending South African Private SchoolsTracy Milondzo, Johanna C Meyer, Carine Dochez, et al.
Vaccines|April 23, 2022
Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid ProteinAnirban Sengupta, Mohammad Azharuddin, Maria E Cardona, et al.
Vaccines|April 23, 2022
The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 VaccinesMonika Skorupa, Joanna Szczepanek, Agnieszka Goroncy, et al.
Vaccines|April 23, 2022
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta VariantOlaf-Oliver Wolz, Sarah-Katharina Kays, Helga Junker, et al.
Pageof 1,003